Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
Ther Adv Neurol Disord
.
2017 Oct;10(10):339-341.
doi: 10.1177/1756285617721093.
Epub 2017 Jul 26.
Authors
Christiane Schneider-Gold
1
,
Anke Reinacher-Schick
2
,
Gisa Ellrichmann
3
,
Ralf Gold
3
Affiliations
1
Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, D-44791, Germany.
2
Department of Hematology, Oncology and Palliative Care, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
3
Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
PMID:
28966662
PMCID:
PMC5607927
DOI:
10.1177/1756285617721093
No abstract available